Skip to main content
  • STRIDE DYSTONIA

    Stride Dystonia is a randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of VIM0423 in individuals with isolated dystonia. The main objectives of this clinical trial are to determine the…

    Investigator
    Aparna A Wagle Shukla
    Ages
    18 Years - 70 Years
    Sexes
    All
  • END-DM1

    Building on previous work of the Myotonic Dystrophy Clinical Research Network (DMCRN), the present study seeks to overcome insufficient data on natural history; lack of reliable biomarkers; and incomplete characterization and limited biological…

    Investigator
    Sub Subramony
    Ages
    18 Years - 70 Years
    Sexes
    All